《大行报告》瑞信升华虹半导体(01347.HK)目标价至49元 评级「中性」
瑞信发表研究报告,指华虹半导体(01347.HK)去年第四季的销量和毛利均胜预期,其中销量按季增11%,受惠8寸和12寸晶圆表现带动,毛利增25.8%,经营溢利反弹至4%,每股盈利增至0.26元。
该行指,华虹半导体今年首季展望亦较高,销量预期录按季增2.8%,主因8寸和12寸晶圆供应紧张,同时公司下半年目标增加付运量,和增加产能,料毛利将降至23-25%,因较多的折旧抵销销售改善。
瑞信表示,华虹半导体今年8寸晶圆继续稳健,而12寸则继续发力,料今年销售增长为38%,升今明两年每股盈利至分别0.84元及0.97元,以各映更好的展望预期,维持「中性」评级,目标价由42元升至49元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.